Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Strategy Asset Managers LLC

Key Points

• Strategy Asset Managers LLC increased its stake in Intuitive Surgical by 38.5%, now holding 4,483 shares valued at $2.22 million.
• Several institutional investors, including Vanguard Group and GAMMA Investing LLC, have significantly boosted their holdings, with institutional ownership now at 83.64%.
• Intuitive Surgical reported Q2 earnings of $2.19 per share, exceeding estimates by $0.26, with year-over-year revenue growth of 21.4%.

Strategy Asset Managers LLC boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 38.5% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 4,483 shares of the medical equipment provider's stock after acquiring an additional 1,247 shares during the quarter. Strategy Asset Managers LLC's holdings in Intuitive Surgical were worth $2,220,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently added to or reduced their stakes in ISRG. Vanguard Group Inc. lifted its holdings in Intuitive Surgical by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider's stock valued at $16,178,258,000 after purchasing an additional 453,335 shares in the last quarter. Northern Trust Corp lifted its holdings in Intuitive Surgical by 15.8% in the 4th quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock valued at $1,889,126,000 after purchasing an additional 494,496 shares in the last quarter. Capital Research Global Investors lifted its holdings in Intuitive Surgical by 25.5% in the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock valued at $1,764,904,000 after purchasing an additional 687,906 shares in the last quarter. GAMMA Investing LLC lifted its holdings in Intuitive Surgical by 54,010.7% in the 1st quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after purchasing an additional 3,022,979 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Intuitive Surgical by 12.8% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,826,972 shares of the medical equipment provider's stock valued at $1,475,566,000 after purchasing an additional 319,694 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Piper Sandler restated an "overweight" rating and issued a $595.00 price objective (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Evercore ISI raised their price objective on Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a report on Tuesday, July 8th. Erste Group Bank restated a "hold" rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. UBS Group raised their price objective on Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a report on Wednesday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft lowered Intuitive Surgical from a "hold" rating to a "sell" rating and reduced their price target for the stock from $515.00 to $440.00 in a report on Monday, June 9th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and an average target price of $595.95.

Intuitive Surgical Trading Down 1.3%

Shares of NASDAQ:ISRG opened at $477.00 on Wednesday. The business has a 50-day moving average price of $521.43 and a 200 day moving average price of $531.52. The company has a market capitalization of $170.99 billion, a price-to-earnings ratio of 66.53, a PEG ratio of 5.07 and a beta of 1.59. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The company's quarterly revenue was up 21.4% on a year-over-year basis. During the same period last year, the company earned $1.78 EPS. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president directly owned 353 shares of the company's stock, valued at $173,845.44. The trade was a 92.73% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the transaction, the senior vice president directly owned 907 shares of the company's stock, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 15,903 shares of company stock valued at $7,932,778. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.